SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-22-008954
Filing Date
2022-05-16
Accepted
2022-05-16 16:16:51
Documents
15
Period of Report
2022-05-16
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ampe-20220516x8k.htm   iXBRL 8-K 38296
2 EX-99.1 ampe-20220516xex99d1.htm EX-99.1 10915
3 EX-99.2 ampe-20220516xex99d2.htm EX-99.2 163600
4 GRAPHIC ampe-20220516xex99d1001.jpg GRAPHIC 4954
  Complete submission text file 0001558370-22-008954.txt   351022

Data Files

Seq Description Document Type Size
5 EX-101.SCH ampe-20220516.xsd EX-101.SCH 3286
6 EX-101.LAB ampe-20220516_lab.xml EX-101.LAB 15367
7 EX-101.PRE ampe-20220516_pre.xml EX-101.PRE 10382
9 EXTRACTED XBRL INSTANCE DOCUMENT ampe-20220516x8k_htm.xml XML 4676
Mailing Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112 720-437-6500
Ampio Pharmaceuticals, Inc. (Filer) CIK: 0001411906 (see all company filings)

IRS No.: 260179592 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35182 | Film No.: 22929286
SIC: 2834 Pharmaceutical Preparations